The determinant role of this enzymatic activity in regulating the cholinergic tone and its brain function was revealed more than 150 years ago, well before the discovery of ACh, with the use of compounds that were later shown to be centrally active anticholinesterase agents.7,8 The observation

that injection of physostigmine causes a rapid modification of mood and temporarily reverses acute mania suggested a TAK-875 cost possible hypersensitivite cholinergic equilibrium.9,10 Although these studies shed a new light on variations in cholinergic tone, they could not tell Inhibitors,research,lifescience,medical which receptors were stimulated by the sustained increase in ACh. With progress in molecular biology and genetics, we now know that ACh acts on two types of receptors: the muscarinic receptors Inhibitors,research,lifescience,medical and the nicotinic receptors. The muscarinic ACh receptors The muscarinic ACh receptors belong to the superfamily of G-coupled proteins, which display the structural characteristics of seven transmembrane proteins (Figure 1A).11 Five

genes encoding muscarinic receptors have been identified to date, and their chromosomic localization determined. Binding of ACh stabilizes the receptor in a conformation that activates G-proteins Inhibitors,research,lifescience,medical present in their vicinity. A further subdivision of the muscarinic receptors in two groups can be made as a function of the second-messenger pathways activated: (i) M1 to M3, which stimulate the hydrolysis of phosphoinositol and trigger an increase in intracellular calcium concentration together with cyclic adenosine monophosphate (cAMP); and (ii) M4 to M5, which inhibit adenylyl cyclase.12 Figure 1. Schematic representation of the cholinergic receptors in the plasma membrane. Inhibitors,research,lifescience,medical A. Side view of the muscarinic receptor with a G-protein complex. Note the N- and C-terminal end of the protein with its seven transmembrane segments. The acetylcholine (ACh) … The nicotinic ACh receptors Neuronal nicotinic ACh receptors (nAChRs), which

will be discussed here, belong Inhibitors,research,lifescience,medical Edoxaban to the family of ligand-gated channels. These receptors constitute both the ligand-binding site and the ionic pore through which ions can flow when the receptor is stabilized in the open conformation. Historically, the existence of such receptors was first revealed in 1857 by Bernard, who showed that the poison curare blocks transmission at the neuromuscular junction, but does not prevent muscle contraction elicited by electrical stimulation. Since this observation, the neuromuscular junction has been used as a reference for synaptic transmission in physiology and pharmacology. It was also recognized a long time ago that ACh is the neurotransmitter that acts on the parasympathetic ganglia, but little was known about the precise mechanisms underlying this neurotransmission.